One of NLSDays’ main aims is to connect investors and life science companies. Thus, several venture capital funds were present during the event in Malmö and BioStock had the chance to speak with representatives from two of these. Johan Kördel, Managing Partner at Sound Bioventures and Tobias Horneman-Thielcke, Partner at Eir Ventures gave an insight into what they were looking for at NLSDays.
Venture capital fund Sound Bioventures invests in private companies in Europe and the US that are approaching clinical phase or that are already in clinical phase. Watch the interview, in Swedish, with Johan Kördel, Managing Partner, below.
Eir Ventures is a life science fund managing 125 MEUR with a special focus on the Nordic region and on stimulating the life science sector in the Nordic countries. Watch the interview with Tobias Horneman-Thielcke, Partner, below.